Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ratajczak, M. Z.
Right arrow Articles by Gewirtz, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ratajczak, M. Z.
Right arrow Articles by Gewirtz, A. M.
Stem Cells, Vol. 14, No. 1, 146-150, January 1996
© 1996 AlphaMed Press


RAPID COMMUNICATION

FLT3/FLK-2 (STK-1) Ligand Does Not Stimulate Human Megakaryopoiesis In Vitro

Mariusz Z. Ratajczaka, Janina Ratajczaka, John Forda, Robert Kregenowa, Wojtek Marlicza, Alan M. Gewirtza,,b

a Department of Pathology and Laboratory Medicine, and
b Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

Key Words. Hematopoiesis • Megakaryocytopoiesis • FLT3/FLK-2 (STK-1) receptor • FLT3/FLK-2 (STK-1) ligand • Growth factors • Antisense oligodeoxynucleotides

Dr. Alan M. Gewirtz, 513B-Stellar-Chance Laboratories, University of Pennsylvania School of Medicine, 422 Curie Blvd., Philadelphia, PA 19104, USA. e-mail: gewirtz{at}a1.mscf.upenn.edu

It has not yet been determined if the FLT3/FLK-2 or STK-1 Ligand (STK-1 L)/FLT3/FLK-2 or STK-1 receptor (STK-1R) axis has the ability to regulate human megakaryopoiesis in vitro. To address this question, we exposed normal human CD34+ marrow mononuclear cells to recombinant human STK-1L alone, or in combination with other growth factors. Colony-forming unit-megakaryocytic/thrombocytes (CFU-Meg) and BFU-E-derived colonies were then enumerated, and effects on colony size and maturation noted. As assessed by these parameters, STK-1L had no demonstrable effect on megakaryocyte colony formation. Similarly, suppressing STK-1R expression with oligodeoxynucleotides also had no influence on CFU-Meg-derived colony formation. To begin to derive a physiologic explanation for these findings, we examined freshly isolated normal human megakaryocytes for the presence of STK-1L and STK-1R mRNA. In contrast to a growing number of growth factors and growth factor receptors which appear to be expressed by megakaryocytes, normal mature human megakaryocytes express neither STK-1R or STK-1L mRNA. Accordingly, our results led us to hypothesize that if STK-1/ STK-1L have any effects on megakaryocyte development in vitro, they are likely subtle and of uncertain physiologic significance.




This article has been cited by other articles:


Home page
BloodHome page
J. L. Williams, G. G. Pipia, N. S. Datta, and M. W. Long
Thrombopoietin Requires Additional Megakaryocyte-Active Cytokines for Optimal Ex Vivo Expansion of Megakaryocyte Precursor Cells
Blood, June 1, 1998; 91(11): 4118 - 4126.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. D. Lyman and S. E. W. Jacobsen
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Blood, February 15, 1998; 91(4): 1101 - 1134.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.stemcellsportal.com/
Copyright © 1996 by AlphaMed Press.